Sarilumab
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Sarilumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $172 million on Sarilumab across 37,000 claims for 6,254 beneficiaries.
Sarilumab is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $2068.06 to $2075.30 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$2068.06 – $2075.30
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sanofi-Aventis U.S. LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Interleukin-6 Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing SARILUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KEVZARA 200 MG/1.14 ML PEN INJ | $2075.2968 per ML | +0.01% |
KEVZARA 200 MG/1.14 ML SYRINGE | $2068.0640 per ML | — |
Frequently Asked Questions
What is Sarilumab used to treat?
Sarilumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Sarilumab?
In 2024, Medicare Part D spent $172 million on Sarilumab across 37,000 claims for 6,254 beneficiaries.
How many Sarilumab products are on the market?
The Sarilumab drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Sarilumab?
NADAC reference prices for Sarilumab range from $2068.0640 to $2075.2968 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Sarilumab?
1 manufacturer lists Sarilumab in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (2).
How has the price of Sarilumab changed recently?
Over the past 7 days, 1 Sarilumab NDC rose and 0 fell, with a market-wide average change of +0.0%.